Skip to main content

Aclaris Therapeutics, Inc. - Common Stock (NQ: ACRS )

2.900 +0.010 (+0.35%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
August 10, 2017
Form 424B5
Source: SEC/Edgar
August 10, 2017
Form 8-K
Source: SEC/Edgar
August 07, 2017
Form 8-K
Source: SEC/Edgar
August 07, 2017
Form 8-K
Source: SEC/Edgar
July 31, 2017
Form DEF 14A
Source: SEC/Edgar
April 20, 2017
Form 8-K
Source: SEC/Edgar
April 20, 2017
Form 8-K
Source: SEC/Edgar
March 14, 2017
Form S-8
Source: SEC/Edgar
March 14, 2017
Form SC 13D/A
Source: SEC/Edgar
March 02, 2017
Form SC 13G/A
Source: SEC/Edgar
February 14, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 07, 2017
Form 8-K
Source: SEC/Edgar
January 25, 2017
Form SC 13D/A
Source: SEC/Edgar
January 17, 2017
Form SC 13G/A
Source: SEC/Edgar
December 20, 2016
Form EFFECT
Source: SEC/Edgar
November 30, 2016
Form POS AM
Source: SEC/Edgar
November 27, 2016
Form SC 13D/A
Source: SEC/Edgar
November 20, 2016
Form 424B3
Source: SEC/Edgar
November 17, 2016
Form 424B5
Source: SEC/Edgar
November 17, 2016
Form 8-K
Source: SEC/Edgar
November 17, 2016
Form 424B5
Source: SEC/Edgar
November 16, 2016
Form 424B3
Source: SEC/Edgar
November 14, 2016
Form 8-K
Source: SEC/Edgar
November 14, 2016
Form EFFECT
Source: SEC/Edgar
November 13, 2016
Form 424B5
Source: SEC/Edgar
November 13, 2016
Form 8-K
Source: SEC/Edgar
November 02, 2016
Form 424B3
Source: SEC/Edgar
November 02, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.